Causal Flows
are statistically significant links between putative causal events (somatic mutations, copy number variations, chromosomal translocations, etc.) and the activity levels of regulators
and regulons
. In the causal flow, a mutation
may causally activate or deactivate a downstream regulator which then might up- down-regulates a regulon that contains genes with similar expression profiles and binding sites.
Causal Mechanistic Flows regulated by Mutation CD22_code_potential_somatic
ID | Mutation | Role | Regulator | Role | Regulon | # downstream regulons | # diffexp regulons | Drugs |
---|---|---|---|---|---|---|---|---|
CMF-12583 | CD22 | up-regulates | ZNF263 | activates | R-556 | 20 | 2 | Drugs (12) Regulator Drugs (0)Regulon Drugs (12)BEVACIZUMAB, CONBERCEPT, PEGAPTANIB SODIUM, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, PROBUCOL, RANIBIZUMAB, FARICIMAB, ABICIPAR PEGOL, AFLIBERCEPT, BROLUCIZUMAB |
CMF-12591 | CD22 | up-regulates | IRF3 | activates | R-2427 | 25 | 2 | Drugs (1) |
CMF-12596 | CD22 | up-regulates | MZF1 | activates | R-1016 | 16 | 4 | Drugs (0) Regulator Drugs (0)Regulon Drugs (0) |
CMF-12597 | CD22 | up-regulates | MZF1 | activates | R-1018 | 16 | 4 | Drugs (12) Regulator Drugs (0)Regulon Drugs (12)BEVACIZUMAB, CONBERCEPT, PEGAPTANIB SODIUM, ENIBARCIMAB, PEGAPTANIB OCTASODIUM, MUPARFOSTAT, VANUCIZUMAB, RANIBIZUMAB, FARICIMAB, ABICIPAR PEGOL, AFLIBERCEPT, BROLUCIZUMAB |
CMF-12599 | CD22 | down-regulates | MSX2 | represses | R-3391 | 6 | 1 | Drugs (8) Regulator Drugs (0)Regulon Drugs (8)GUANIDINE, GUANIDINE HYDROCHLORIDE, AMIFAMPRIDINE PHOSPHATE, DALFAMPRIDINE, TEDISAMIL, NERISPIRDINE, AMIFAMPRIDINE, TOSEDOSTAT |